Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
MODERN: An Integrated Phase II/III and Phase III Trial of MRD-Based Optimization of Adjuvant Therapy in Urothelial Cancer
Study Type: Treatment
Phase: II/III
NCTID: NCT05987241
Principal Investigator:
Saqib Abbasi
A Window of Opportunity Study to Characterize the Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics of CPX-POM in Patients with Newly Diagnosed or Recurrent Bladder Tumors
A Randomized Open-Label Phase II/III Study of BT8009 as Monotherapy or in Combination in Participants with Locally Advanced or Metastatic Urothelial Cancer Duravelo-2
Longitudinal Geriatric Assessment to Optimize Outcomes of Older Patients with Muscle?Invasive Bladder Cancer after Radical Cystectomy: A Pilot Trial
Study Type: Supportive Care
Phase: Feasibility/Pilot
NCTID: NCT05335707
Principal Investigator:
Elizabeth Wulff-Burchfield
A phase II study of gemcitabine plus cisplatin chemotherapy in patients with muscle-invasive bladder cancer with bladder preservation for those patients whose tumors harbor deleterious DNA damage response DDR gene alterations
A Phase III, Randomized, Open-Label, Multi-Center, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination with Gemcitabine+Cisplatin for Neoadjuvant Treatment Followed by Durvalumab Alone for Adjuvant Treatment in Patients with Muscle-Invasive Bladder Cancer NIAGARA
A Phase III Randomized Trial of Eribulin NSC 707389 with Gemcitabine Versus Standard of Care Physician's Choice for Treatment of Metastatic Urothelial Carcinoma Refractory to, or Ineligible for, Anti PD1/PDL1 Therapy
Study Type: Treatment
Phase: III
NCTID: NCT04579224
Principal Investigator:
Saqib Abbasi